BeStock  
Stocks › Biotechnology › DMRA

Damora Therapeutics DMRA

US equityMarket cap rank #2901Biotechnology
$23.22 −$1.08 (-4.44%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $23.22 0.00%
Open$23.81
Prev close$24.30
Day range$23.13 – $24.51
Volume643.4K
Market cap$1.44B
P/E (TTM)13.6
Dividend yield–

DMRA Stock News

Headlines matching Damora Therapeutics or the DMRA ticker, most recent first.

  • Wedbush Maintains Damora Therapeutics(DMRA.US) With Buy Rating, Maintains Target Price $40Market news · 29 Sep 2026 · Direct mention
  • Guggenheim Maintains Damora Therapeutics(DMRA.US) With Buy Rating, Raises Target Price to $60 PositiveMarket news · 25 Sep 2026 · Direct mention
  • LifeSci Capital Maintains Damora Therapeutics(DMRA.US) With Buy Rating, Maintains Target Price $45Market news · 19 Sep 2026 · Direct mention
  • H.C. Wainwright Maintains Damora Therapeutics(DMRA.US) With Buy Rating, Maintains Target Price $45Market news · 6 Aug 2026 · Direct mention
  • A Quick Look at Today's Ratings for Damora Therapeutics(DMRA.US), With a Forecast Between $40 to $50Market news · 12 Aug 2026 · Direct mention
  • A Quick Look at Today's Ratings for Damora Therapeutics(DMRA.US), With a Forecast Between $40 to $45Market news · 11 Aug 2026 · Direct mention
  • Wedbush Maintains Damora Therapeutics(DMRA.US) With Buy Rating, Raises Target Price to $40 PositiveMarket news · 30 Jul 2026 · Direct mention
  • Jefferies Initiates Damora Therapeutics(DMRA.US) With Buy Rating, Announces Target Price $50Market news · 27 Jul 2026 · Direct mention
  • TD Cowen Initiates Damora Therapeutics(DMRA.US) With Buy RatingMarket news · 8 Jun 2026 · Direct mention
  • RBC Capital Maintains Damora Therapeutics(DMRA.US) With Buy Rating, Maintains Target Price $40Market news · 30 Jun 2026 · Direct mention
  • Wedbush Maintains Damora Therapeutics(DMRA.US) With Buy Rating, Maintains Target Price $35Market news · 16 Jun 2026 · Direct mention
  • Guggenheim Maintains Damora Therapeutics(DMRA.US) With Buy Rating, Maintains Target Price $40Market news · 15 Jun 2026 · Direct mention
  • TD Cowen Maintains Damora Therapeutics(DMRA.US) With Buy RatingMarket news · 12 Jun 2026 · Direct mention
  • H.C. Wainwright Initiates Damora Therapeutics(DMRA.US) With Buy Rating, Announces Target Price $45Market news · 11 Jun 2026 · Direct mention
  • Wedbush Initiates Damora Therapeutics(DMRA.US) With Buy Rating, Announces Target Price $35Market news · 28 May 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on DMRA.

Sign in to join the discussion.

Scroll to Top